These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 32501293)

  • 1. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease.
    Zhao Y; Qin L; Zhang P; Li K; Liang L; Sun J; Xu B; Dai Y; Li X; Zhang C; Peng Y; Feng Y; Li A; Hu Z; Xiang H; Ogg G; Ho LP; McMichael A; Jin R; Knight JC; Dong T; Zhang Y
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32501293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow resolution of inflammation in severe adult dengue patients.
    Zhao L; Huang X; Hong W; Qiu S; Wang J; Yu L; Zeng Y; Tan X; Zhang F
    BMC Infect Dis; 2016 Jun; 16():291. PubMed ID: 27301555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
    Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.
    Remy KE; Mazer M; Striker DA; Ellebedy AH; Walton AH; Unsinger J; Blood TM; Mudd PA; Yi DJ; Mannion DA; Osborne DF; Martin RS; Anand NJ; Bosanquet JP; Blood J; Drewry AM; Caldwell CC; Turnbull IR; Brakenridge SC; Moldwawer LL; Hotchkiss RS
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32687484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Inflammatory Response to Severe COVID-19 Illness.
    McElvaney OJ; McEvoy NL; McElvaney OF; Carroll TP; Murphy MP; Dunlea DM; Ní Choileáin O; Clarke J; O'Connor E; Hogan G; Ryan D; Sulaiman I; Gunaratnam C; Branagan P; O'Brien ME; Morgan RK; Costello RW; Hurley K; Walsh S; de Barra E; McNally C; McConkey S; Boland F; Galvin S; Kiernan F; O'Rourke J; Dwyer R; Power M; Geoghegan P; Larkin C; O'Leary RA; Freeman J; Gaffney A; Marsh B; Curley GF; McElvaney NG
    Am J Respir Crit Care Med; 2020 Sep; 202(6):812-821. PubMed ID: 32584597
    [No Abstract]   [Full Text] [Related]  

  • 7. An inflammatory cytokine signature predicts COVID-19 severity and survival.
    Del Valle DM; Kim-Schulze S; Huang HH; Beckmann ND; Nirenberg S; Wang B; Lavin Y; Swartz TH; Madduri D; Stock A; Marron TU; Xie H; Patel M; Tuballes K; Van Oekelen O; Rahman A; Kovatch P; Aberg JA; Schadt E; Jagannath S; Mazumdar M; Charney AW; Firpo-Betancourt A; Mendu DR; Jhang J; Reich D; Sigel K; Cordon-Cardo C; Feldmann M; Parekh S; Merad M; Gnjatic S
    Nat Med; 2020 Oct; 26(10):1636-1643. PubMed ID: 32839624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
    Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
    Wang J; Jiang M; Chen X; Montaner LJ
    J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
    Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
    Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon gamma, TGF-β1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients.
    Montalvo Villalba MC; Valdés Ramírez O; Muné Jiménez M; Arencibia Garcia A; Martinez Alfonso J; González Baéz G; Roque Arrieta R; Rosell Simón D; Alvárez Gainza D; Sierra Vázquez B; Resik Aguirre S; Guzmán Tirado MG
    Clin Immunol; 2020 Nov; 220():108576. PubMed ID: 32866645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xuebijing injection in the treatment of COVID-19: a retrospective case-control study.
    Guo H; Zheng J; Huang G; Xiang Y; Lang C; Li B; Huang D; Sun Q; Luo Y; Zhang Y; Huang L; Fang W; Zheng Y; Wan S
    Ann Palliat Med; 2020 Sep; 9(5):3235-3248. PubMed ID: 32954754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
    Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X
    EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Interleukin 6 inhibitors in therapy of severe COVID-19.
    Nasonov E; Samsonov M
    Biomed Pharmacother; 2020 Nov; 131():110698. PubMed ID: 32920514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients.
    Burgos-Blasco B; Güemes-Villahoz N; Santiago JL; Fernandez-Vigo JI; Espino-Paisán L; Sarriá B; García-Feijoo J; Martinez-de-la-Casa JM
    Exp Eye Res; 2020 Nov; 200():108253. PubMed ID: 32949577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
    Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
    Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection.
    Gadotti AC; de Castro Deus M; Telles JP; Wind R; Goes M; Garcia Charello Ossoski R; de Padua AM; de Noronha L; Moreno-Amaral A; Baena CP; Tuon FF
    Virus Res; 2020 Nov; 289():198171. PubMed ID: 32979474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.